{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T15:08:51Z","timestamp":1767020931822,"version":"3.48.0"},"reference-count":162,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04527-x","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T14:19:35Z","timestamp":1767017975000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of combined Metformin and pharmaceutical molecules with anti-androgenic properties in the therapy of PCOS in adult women"],"prefix":"10.1007","volume":"91","author":[{"given":"Athanasios","family":"Antoniou-Tsigkos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Karras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Papagianni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Christopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"F Vlahos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Mastorakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"4527_CR1","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","volume":"91","author":"R Azziz","year":"2009","unstructured":"R. Azziz et al., The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil. Steril. 91, 456\u2013488 (2009)","journal-title":"Fertil. Steril."},{"key":"4527_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/CLEP.S37559","volume":"6","author":"SM Sirmans","year":"2013","unstructured":"S.M. Sirmans, K.A. Pate, Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin. Epidemiol. 6, 1 (2013)","journal-title":"Clin. Epidemiol."},{"issue":"36","key":"4527_CR3","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.2174\/1381612827666210119104721","volume":"27","author":"J Bjeki\u0107-Macut","year":"2021","unstructured":"J. Bjeki\u0107-Macut, T. Vuka\u0161in, Z. Velija-A\u0161imi et al., Polycystic ovary syndrome: A contemporary clinical approach. Curr. Pharm. Des. 27(36), 3812\u20133820 (2021)","journal-title":"Curr. Pharm. Des."},{"key":"4527_CR4","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1210\/jc.2003-032046","volume":"89","author":"R Azziz","year":"2004","unstructured":"R. Azziz et al., The prevalence and features of the polycystic ovary syndrome in an unselected population. J. Clin. Endocrinol. Metab. 89, 2745\u20132749 (2004)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4527_CR5","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1530\/EJE-14-0253","volume":"171","author":"G Conway","year":"2014","unstructured":"G. Conway et al., The polycystic ovary syndrome: a position statement from the European society of endocrinology. Eur. J. Endocrinol. 171, P1\u201329 (2014)","journal-title":"Eur. J. Endocrinol."},{"key":"4527_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.coemr.2020.02.013","volume":"12","author":"DA Dumesic","year":"2020","unstructured":"D.A. Dumesic, D.H. Abbott, S. Sanchita, G.D. Chazenbalk, Endocrine-Metabolic dysfunction in polycystic ovary syndrome: an evolutionary perspective. Curr. Opin. Endocr. Metab. Res. 12, 41\u201348 (2020)","journal-title":"Curr. Opin. Endocr. Metab. Res."},{"issue":"3","key":"4527_CR7","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1210\/jc.2010-0130","volume":"96","author":"C Marios","year":"2011","unstructured":"C. Marios, D. Markopoulos, G. Rizos, Valsamakis et al., Hyperandrogenism in women with polycystic ovary syndrome persists after menopause. J. Clin. Endocrinol. Metab. 96(3), 623\u2013631 (2011)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4527_CR8","first-page":"377","volume-title":"Polycystic Ovary Syndrome","author":"JK Zawadzki","year":"1992","unstructured":"J.K. Zawadzki, A. Dunaif, Polycystic Ovary Syndrome, ed. by A. Dunaif, J.R. Givens, F.P. Haseltine, G.R. Merriam (Blackwell Scientific, Boston, MA, USA, 1992), pp. 377\u2013384"},{"key":"4527_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"The Rotterdam ESHRE\/ASRM-sponsored PCOS consensus workshop group","year":"2004","unstructured":"The Rotterdam ESHRE\/ASRM-sponsored PCOS consensus workshop group, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod. 19, 41\u201347 (2004)","journal-title":"Hum. Reprod."},{"key":"4527_CR10","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.1210\/jc.2006-0178","volume":"91","author":"R Azziz","year":"2006","unstructured":"R. Azziz et al., Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. J. Clin. Endocrinol. Metab. 91, 4237\u20134245 (2006)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4527_CR11","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1159\/000375530","volume":"83","author":"SF Witchel","year":"2015","unstructured":"S.F. Witchel, S. Oberfield, R.L. Rosenfield et al., The diagnosis of polycystic ovary syndrome during adolescence. Horm. Res. Paediatr. 83, 376\u2013389 (2015)","journal-title":"Horm. Res. Paediatr."},{"key":"4527_CR12","doi-asserted-by":"publisher","first-page":"201e1","DOI":"10.1016\/j.ajog.2010.03.008","volume":"203","author":"E Carmina","year":"2010","unstructured":"E. Carmina, S.E. Oberfield, R. Lobo, The diagnosis of polycystic in adolescents. Am. J. Obstet. Gynecol. 203, 201e1\u2013e5 (2010)","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"4527_CR13","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1159\/000479371","volume":"88","author":"L Ib\u00e1\u00f1ez","year":"2017","unstructured":"L. Ib\u00e1\u00f1ez, S.E. Oberfield, S. Witchel, An International Consortium Update et al., Pathophysiology, Diagnosis, and treatment of polycystic ovarian syndrome in adolescence. Horm. Res. Paediatr. 88(6), 371 (2017). Epub 2017 Nov 13","journal-title":"Horm. Res. Paediatr."},{"issue":"3","key":"4527_CR14","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","volume":"110","author":"HJ Teede","year":"2018","unstructured":"H.J. Teede, M.L. Misso, M.F. Costello et al., International PCOS Network. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil. Steril. 110(3), 364 (2018). Epub 2018 Jul 19","journal-title":"Fertil. Steril."},{"issue":"12","key":"4527_CR15","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1210\/jc.2013-2350","volume":"12","author":"RS Legro","year":"2013","unstructured":"R.S. Legro, S.A. Arslanian, D.A. Ehrmann et al., Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 12(12), 4565\u20134592 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"4527_CR16","doi-asserted-by":"publisher","first-page":"4965","DOI":"10.1210\/jc.2010-0202","volume":"11","author":"EB Johnstone","year":"2010","unstructured":"E.B. Johnstone, M.P. Rosen, R. Neril et al., The polycystic ovary post-rotterdam: a common, age dependent finding in ovulatory women without metabolic significance. J. Clin. Endocrinol. Metab. 11(11), 4965\u20134972 (2010)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"4527_CR17","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1210\/jc.2018-00241","volume":"103","author":"KA Martin","year":"2018","unstructured":"K.A. Martin, R.R. Anderson, R.J. Chang et al., Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 103(4), 1233 (2018)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"4527_CR18","first-page":"e106","volume":"10","author":"Screening and Management of the Hyperandrogenic Adolescent","year":"2019","unstructured":"Screening and Management of the Hyperandrogenic Adolescent, ACOG committee Opinion, number 789. Obstet. Gynecol. 10(4), e106\u2013e114 (2019)","journal-title":"Obstet. Gynecol."},{"issue":"4","key":"4527_CR19","doi-asserted-by":"publisher","first-page":"E628","DOI":"10.1210\/jc.2012-3908","volume":"4","author":"P Moghetti","year":"2013","unstructured":"P. Moghetti, F. Tosi, C. Bonin et al., Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 4(4), E628\u2013E637 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"4527_CR20","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1210\/jc.2004-2279","volume":"5","author":"E Carmina","year":"2005","unstructured":"E. Carmina, M.C. Chu, R.A. Longo et al., Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters. J. Clin. Endocrinol. Metab. 5(5), 2545\u20132549 (2005). [PubMed: 15728203]","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4527_CR21","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1210\/er.2011-1034","volume":"6","author":"A Dunaif","year":"2012","unstructured":"Evanthia Diamanti-Kandarakis, A. Dunaif, Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr. Rev. 6, 981\u20131030 (2012)","journal-title":"Endocr. Rev."},{"issue":"1","key":"4527_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ecl.2020.10.002","volume":"50","author":"Sydney","year":"2021","unstructured":"Sydney, Chang, Andrea Dunaif diagnosis of polycystic ovary syndrome: which criteria to use and when? Endocrinol. Metab. Clin. North. Am. 50(1), 11\u201323 (2021)","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"key":"4527_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrendo.2013.256","volume":"10","author":"I Pernicova","year":"2014","unstructured":"I. Pernicova, M. Korbonits, Metformin-\u2010mode of action and clinical implications for diabetes and cancer. Nat. Rev. Endocrinol. 10, 143\u2013156 (2014)","journal-title":"Nat. Rev. Endocrinol."},{"issue":"4","key":"4527_CR24","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1210\/jc.2007-2430","volume":"93","author":"BA Swiglo","year":"2008","unstructured":"B.A. Swiglo, M. Cosma, D.N. Flynn et al., Clinical review: antiandrogens for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials. J. Clin. Endocrinol. Metab. 93(4), 1153 (2008). Epub 2008 Feb 5","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6821","key":"4527_CR25","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/35055575","volume":"409","author":"ED Abel","year":"2001","unstructured":"E.D. Abel, O. Peroni, J.K. Kim et al., Adiposeselective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature. 409(6821), 729\u2013733 (2001)","journal-title":"Nature"},{"key":"4527_CR26","doi-asserted-by":"publisher","first-page":"500","DOI":"10.2337\/diacare.11.6.500","volume":"11","author":"ME Geffner","year":"1988","unstructured":"M.E. Geffner, D.W. Golde, Selective insulin action on skin, ovary, and heart in insulin-resistant States. Diabetes Care. 11, 500\u2013505 (1988)","journal-title":"Diabetes Care"},{"key":"4527_CR27","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.2337\/diab.41.10.1257","volume":"41","author":"A Dunaif","year":"1992","unstructured":"A. Dunaif, K.R. Segal, D.R. Shelley et al., Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes. 41, 1257\u20131266 (1992)","journal-title":"Diabetes"},{"key":"4527_CR28","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/humrep\/des463","volume":"28","author":"NK Stepto","year":"2013","unstructured":"N.K. Stepto, S. Cassar, A.E. Joham et al., Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic hyperinsulaemic clamp. Hum. Reprod. 28, 777\u2013784 (2013)","journal-title":"Hum. Reprod."},{"key":"4527_CR29","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.fertnstert.2014.04.004","volume":"102","author":"A Morciano","year":"2014","unstructured":"A. Morciano, F. Romani, F. Sagnella et al., Assessment of insulin resistance in lean women with polycystic ovary syndrome. Fertil. Steril. 102, 250\u2013256 (2014)","journal-title":"Fertil. Steril."},{"issue":"5","key":"4527_CR30","doi-asserted-by":"publisher","first-page":"E765","DOI":"10.1210\/jc.2011-2377","volume":"97","author":"Y-H Gregorio Chazenbalk","year":"2012","unstructured":"Y.-H. Gregorio Chazenbalk, S. Chen, Heneidi et al., Abnormal expression of genes involved in Inflammation, lipid Metabolism, and Wnt signaling in the adipose tissue of polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 97(5), E765\u2013E770 (2012)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4527_CR31","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1210\/er.2004-0004","volume":"26","author":"HF Escobar-Morreale","year":"2005","unstructured":"H.F. Escobar-Morreale, M. Luque-Ram\u00edrez, J.L. San Millan, The molecular genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocr. Rev. 26, 251\u2013282 (2005)","journal-title":"Endocr. Rev."},{"key":"4527_CR32","doi-asserted-by":"publisher","first-page":"189e1","DOI":"10.1016\/j.ajog.2017.04.007","volume":"217","author":"JL Chan","year":"2017","unstructured":"J.L. Chan, S. Kar, E. Vanky, L. Morin-Papunen, T. Piltonen, J. Puurunen et al., Racial and ethnic differences in the prevalence of metabolic syndrome and its components of metabolic syndrome in women with polycystic ovary syndrome: a regional cross-sectional study. Am. J. Obstet. Gynecol. 217, 189e1\u2013e8 (2017)","journal-title":"Am. J. Obstet. Gynecol."},{"key":"4527_CR33","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/j.1365-2265.2010.03873.x","volume":"73","author":"D Glintborg","year":"2010","unstructured":"D. Glintborg, H. Mumm, D. Hougaard, P. Ravn, M. Andersen, Ethnic differences in Rotterdam criteria and metabolic risk factors in a multiethnic group of women with PCOS studied in Denmark. Clin. Endocrinol. (Oxf). 73, 732\u2013738 (2010)","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"4527_CR34","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.steroids.2013.04.006","volume":"78","author":"Y Zhao","year":"2013","unstructured":"Y. Zhao, J. Qiao, Ethnic differences in the phenotypic expression of polycystic ovary syndrome. Steroids. 78, 755\u2013760 (2013)","journal-title":"Steroids"},{"issue":"1","key":"4527_CR35","first-page":"16","volume":"106","author":"SS Merkin","year":"2016","unstructured":"S.S. Merkin, J.L. Phy, K. Cynthia, Sites, Dongzi Yang. Environ. Determinants Polycystic Ovary Syndrome Fertil. Steril. 106(1), 16\u201324 (2016)","journal-title":"Environ. Determinants Polycystic Ovary Syndrome Fertil. Steril."},{"key":"4527_CR36","doi-asserted-by":"publisher","first-page":"R11","DOI":"10.1530\/REP-14-0499","volume":"150","author":"AS de Melo","year":"2015","unstructured":"de A.S. Melo, S.V. Dias, C. Cavalli Rde, V.C. Cardoso, H. Bettiol, M.A. Barbieri et al., Pathogenesis of polycystic ovary syndrome: multifactorial assessment from the foetal stage to menopause. Reproduction. 150, R11\u201324 (2015)","journal-title":"Reproduction"},{"issue":"3","key":"4527_CR37","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.tem.2019.01.005","volume":"30","author":"A Zaher Merhi, Eleni","year":"2019","unstructured":"A. Zaher Merhi, Eleni, Kandaraki, Evanthia Diamanti-Kandarakis. Implications and future perspectives of ages in PCOS pathophysiology. Rev. Trends Endocrinol. Metab. 30(3), 150\u2013162 (2019)","journal-title":"Rev. Trends Endocrinol. Metab."},{"key":"4527_CR38","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1093\/humupd\/dms030","volume":"18","author":"SS Lim","year":"2012","unstructured":"S.S. Lim, M.J. Davies, R.J. Norman, L.J. Moran, Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum. Reprod. Update. 18, 618\u2013637 (2012)","journal-title":"Hum. Reprod. Update"},{"key":"4527_CR39","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1093\/oxfordjournals.humrep.a136243","volume":"10","author":"AH Balen","year":"1995","unstructured":"A.H. Balen, G.S. Conway, G. Kaltsas, K. Techatrasak, P.J. Man ning, C. West et al., Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum. Reprod. 10, 2107\u20132111 (1995)","journal-title":"Hum. Reprod."},{"key":"4527_CR40","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1365-2265.2006.02587.x","volume":"65","author":"TM Barber","year":"2006","unstructured":"T.M. Barber, M.I. McCarthy, J.A. Wass, S. Franks, Obesity and polycystic ovary syndrome. Clin. Endocrinol. (Oxf). 65, 137\u2013145 (2006)","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"4527_CR41","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1210\/jc.2004-2279","volume":"90","author":"E Carmina","year":"2005","unstructured":"E. Carmina, M.C. Chu, R.A. Longo, G.B. Rini, R.A. Lobo, Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters. J. Clin. Endocrinol. Metab. 90, 2545\u20132549 (2005)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4527_CR42","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.fertnstert.2014.06.027","volume":"102","author":"L Chen","year":"2014","unstructured":"L. Chen, W.M. Xu, D. Zhang, Association of abdominal obesity, insulin resistance, and oxidative stress in adipose tissue in women with polycystic ovary syndrome. Fertil. Steril. 102, 1167\u20131174 (2014)","journal-title":"Fertil. Steril."},{"key":"4527_CR43","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0026-0495(99)90100-2","volume":"48","author":"F Gonzalez","year":"1999","unstructured":"F. Gonzalez, K. Thusu, E. Abdel-Rahman, A. Prabhala, M. Tomani, P. Dandona, Elevated serum levels of tumor necrosis factor \u03b1 in normal-weight women with polycystic ovary syndrome. Metabolism. 48, 437\u2013441 (1999)","journal-title":"Metabolism"},{"key":"4527_CR44","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.fertnstert.2011.11.023","volume":"97","author":"AJ Duleba","year":"2012","unstructured":"A.J. Duleba, A. Dokras, Is PCOS an inflammatory process? Fertil. Steril. 97, 7\u201312 (2012)","journal-title":"Fertil. Steril."},{"key":"4527_CR45","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1172\/JCI25102","volume":"115","author":"KE Wellen","year":"2005","unstructured":"K.E. Wellen, G.S. Hotamisligil, Inflammation, stress, and diabetes. J. Clin. Invest. 115, 1111\u20131119 (2005)","journal-title":"J. Clin. Invest."},{"key":"4527_CR46","doi-asserted-by":"publisher","first-page":"222","DOI":"10.2119\/2007-00119.Tilg","volume":"14","author":"H Tilg","year":"2008","unstructured":"H. Tilg, A.R. Moschen, Inflammatory mechanisms in the regulation of insulin resistance. Mol. Med. 14, 222\u2013231 (2008)","journal-title":"Mol. Med."},{"issue":"5","key":"4527_CR47","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1074\/jbc.M208359200","volume":"278","author":"YH Lee","year":"2003","unstructured":"Y.H. Lee, J. Giraud, R.J. Davis et al., c-Jun N-terminal kinase (JNK) mediates feedback Inhibition of the insulin signaling cascade. J. Biol. Chem. 278(5), 2896\u20132902 (2003)","journal-title":"J. Biol. Chem."},{"issue":"12","key":"4527_CR48","doi-asserted-by":"publisher","first-page":"9047","DOI":"10.1074\/jbc.275.12.9047","volume":"275","author":"V Aguirre","year":"2000","unstructured":"V. Aguirre, T. Uchida, L. Yenush et al., The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J. Biol. Chem. 275(12), 9047\u20139054 (2000)","journal-title":"J. Biol. Chem."},{"issue":"9","key":"4527_CR49","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1055\/s-2005-870426","volume":"37","author":"G Mastorakos","year":"2005","unstructured":"G. Mastorakos 1, M. Pavlatou, Exercise as a stress model and the interplay between the hypothalamus-pituitary-adrenal and the hypothalamus-pituitary-thyroid axes. Horm. Metab. Res. 37(9), 577\u2013584 (2005)","journal-title":"Horm. Metab. Res."},{"issue":"12","key":"4527_CR50","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1038\/s41366-018-0075-4","volume":"42","author":"P Ormazabal","year":"2018","unstructured":"P. Ormazabal, B. Scazzocchio, R. Vari et al., Effect of Protocatechuic acid on insulin responsiveness and inflammation in visceral adipose tissue from obese individuals: possible role for PTP1B. Int. J. Obes. 42(12), 2012\u20132021 (2018)","journal-title":"Int. J. Obes."},{"issue":"3","key":"4527_CR51","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1002\/jcb.27643","volume":"120","author":"S Mangali","year":"2019","unstructured":"S. Mangali, A. Bhat, M.P. Udumula et al., Inhibition of protein kinase R protects against palmitic acid-induced inflammation, oxidative stress, and apoptosis through the JNK\/NF-kB\/NLRP3 pathway in cultured H9C2 cardiomyocytes. J. Cell. Biochem. 120(3), 3651\u20133663 (2019). https:\/\/doi.org\/10.1002\/jcb.27643","journal-title":"J. Cell. Biochem."},{"issue":"6","key":"4527_CR52","first-page":"623","volume":"22","author":"EDC Ruelas Cinco","year":"2019","unstructured":"E.D.C. Ruelas Cinco, B. Ruiz Madrigal, J.A. Dominguez Rosales et al., Expression of the receptor of advanced glycation end-products (RAGE) and membranal location in peripheral blood mononuclear cells (PBMC) in obesity and insulin resistance. Iran. J. Basic. Med. Sci. 22(6), 623\u2013630 (2019)","journal-title":"Iran. J. Basic. Med. Sci."},{"issue":"3","key":"4527_CR53","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nm.3084","volume":"19","author":"S Kiechl","year":"2013","unstructured":"S. Kiechl, J. Wittmann, A. Giaccari et al., Blockade of receptor acti vator of nuclear factor-kappaB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus. Nat. Med. 19(3), 358\u2013363 (2013). https:\/\/doi.org\/10.1038\/nm.3084","journal-title":"Nat. Med."},{"key":"4527_CR54","doi-asserted-by":"publisher","first-page":"E304","DOI":"10.1210\/jc.2010-1290","volume":"96","author":"L. Manner\u00e5s-Holm","year":"2011","unstructured":"L. Manner\u00e5s-Holm, H. Leonhardt, J. Kullberg et al., adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not Circulating sex steroids, are strongly associated with insulin resistance. J. Clin. Endocrinol. Metab. 96, E304\u2013E311 (2011) https:\/\/doi.org\/10.1210\/jc.2010-1290","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"4527_CR55","first-page":"705","volume":"167","author":"T Tao","year":"2012","unstructured":"T. Tao, S. Li, A. Zhao, Expression of the CD11c gene in subcutaneous adipose tissue is associated with cytokine level and insulin resistance in women with polycystic ovary syndrome Eur. J. Endocrinol. 167(5), 705\u2013713 (2012)","journal-title":"J. Endocrinol."},{"key":"4527_CR56","doi-asserted-by":"publisher","unstructured":"S. Sam, Dunaif A 2003 Polycystic Ovary Syndrome: Syndrome XX? Trends Endocrinol Metab https:\/\/doi.org\/10.1016\/j.tem.2003.08.002","DOI":"10.1016\/j.tem.2003.08.002"},{"key":"4527_CR57","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.fertnstert.2005.10.054","volume":"85","author":"R Pasquali","year":"2006","unstructured":"R. Pasquali, Obesity and androgens: facts and perspectives. Fertil. Steril. 85, 1319\u20131340 (2006)","journal-title":"Fertil. Steril."},{"issue":"2","key":"4527_CR58","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000160911","volume":"89","author":"M Moret","year":"2009","unstructured":"M. Moret, R. Stettler, F. Rodieux et al., Insulin modulation of luteinizing hormone secretion in normal female volunteers and lean polycystic ovary syndrome patients. Neuroendocrinology. 89(2), 131\u2013139 (2009)","journal-title":"Neuroendocrinology"},{"issue":"6","key":"4527_CR59","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1016\/j.fertnstert.2007.09.016","volume":"90","author":"C Moran","year":"2008","unstructured":"C. Moran, J.L. Renteria, S. Moran et al., Obesity differentially affects serum levels of Androstenedione and testosterone in polycystic ovary syndrome. Fertil. Steril. 90(6), 2310\u20132317 (2008)","journal-title":"Fertil. Steril."},{"issue":"5","key":"4527_CR60","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/j.fertnstert.2008.02.120","volume":"91","author":"F Sagnella","year":"2009","unstructured":"F. Sagnella, R. Apa, M. Guido et al., Suppression and recovery of gonadotropin and steroid secretion by a gonadotropin-releasing hormone receptor antagonist in healthy women with normal ovulation versus women with polycystic ovary syndrome in the early follicular phase. Fertil. Steril. 91(5), 1857\u20131863 (2009)","journal-title":"Fertil. Steril."},{"issue":"5","key":"4527_CR61","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.fertnstert.2008.02.091","volume":"89","author":"AA Bremer","year":"2008","unstructured":"A.A. Bremer, W.L. Miller, The Serine phosphorylation hypothesis of polycystic ovary syndrome: a unifying mechanism for hyperandrogenemia and insulin resistance. Fertil. Steril. 89(5), 1039\u20131048 (2008)","journal-title":"Fertil. Steril."},{"issue":"6","key":"4527_CR62","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1016\/j.fertnstert.2007.09.016","volume":"90","author":"C Moran","year":"2008","unstructured":"C. Moran, J.L. Renteria, S. Moran, J. Herrera, S. Gonzalez, J.A. Bermudez, Obesity differentially affects serum levels of Androstenedione and testosterone in polycystic ovary syndrome. Fertil. Steril. 90(6), 2310\u20132317 (2008)","journal-title":"Fertil. Steril."},{"issue":"5","key":"4527_CR63","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/j.fertnstert.2007.01.032","volume":"88","author":"R Shroff","year":"2007","unstructured":"R. Shroff, C.H. Syrop, W. Davis, Van B.J. Voorhis, A. Dokras, Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria. Fertil. Steril. 88(5), 1389\u20131395 (2007)","journal-title":"Fertil. Steril."},{"issue":"5","key":"4527_CR64","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0015-0282(16)53510-9","volume":"53","author":"RL Rosenfield","year":"1990","unstructured":"R.L. Rosenfield, R.B. Barnes, J.F. Cara et al., Dysregulation of cytochrome P450c 17 alpha as the cause of polycystic ovarian syndrome. Fertil. Steril. 53(5), 785 (1990)","journal-title":"Fertil. Steril."},{"issue":"3","key":"4527_CR65","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1210\/edrv-6-3-400","volume":"6","author":"EY Adashi","year":"1985","unstructured":"E.Y. Adashi, C.E. Resnick, A.J. D\u2019Ercole et al., Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function. Endocr. Rev. 6(3), 400 (1985)","journal-title":"Endocr. Rev."},{"issue":"3","key":"4527_CR66","doi-asserted-by":"publisher","first-page":"751","DOI":"10.2337\/diabetes.55.03.06.db05-0453","volume":"55","author":"A Corbould","year":"2006","unstructured":"A. Corbould, H. Zhao, S. Mirzoeva et al., Enhanced mitogenic signaling in skeletal muscle of women with polycystic ovary syndrome. Diabetes. 55(3), 751\u2013759 (2006)","journal-title":"Diabetes"},{"key":"4527_CR67","doi-asserted-by":"publisher","unstructured":"E. Ricardo Azziz, Z.J. Carmina, Chen et al., Polycystic Ovary Syndrome Nat. Rev. Dis. Primers 2016 Aug 11:2:16057 https:\/\/doi.org\/10.1038\/nrdp.2016.57","DOI":"10.1038\/nrdp.2016.57"},{"key":"4527_CR68","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S0889-8529(05)70074-8","volume":"28","author":"S Franks","year":"1999","unstructured":"S. Franks, C. Gilling-Smith, H. Watson, D. Willis, Insulin action in the normal and polycystic ovary. Endocrinol. Metab. Clin. North. Am. 28, 361\u2013367 (1999)","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"key":"4527_CR69","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1093\/humrep\/12.11.2469","volume":"12","author":"Y Lin","year":"1997","unstructured":"Y. Lin, M. Fridstrom, T. Hillensjo, Insulin stimulation of lactate Accu mulation in isolated human granulosa-luteal cells: a comparison between normal and polycystic ovaries. Hum. Reprod. 12, 2469\u20132472 (1997)","journal-title":"Hum. Reprod."},{"key":"4527_CR70","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/S0015-0282(00)00688-9","volume":"74","author":"XK Wu","year":"2000","unstructured":"X.K. Wu, K. Sallinen, L. Anttila et al., Expression of insulin-receptor substrate-1 and \u2013\u20092 in ovaries from women with insulin resistance and from controls. Fertil. Steril. 74, 564\u2013572 (2000)","journal-title":"Fertil. Steril."},{"issue":"4","key":"4527_CR71","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.cell.2011.10.026","volume":"147","author":"N Mizushima","year":"2011","unstructured":"N. Mizushima, M. Komatsu, Autophagy: renovation of cells and tissues. Cell. 147(4), 728\u2013741 (2011)","journal-title":"Cell"},{"issue":"7","key":"4527_CR72","doi-asserted-by":"publisher","first-page":"9563","DOI":"10.1096\/fj.202000605RR","volume":"34","author":"C Zhang","year":"2020","unstructured":"C. Zhang, J. Hu, W. Wang et al., HMGB1-induced aberrant autophagy contributes to insulin resistance in granulosa cells in PCOS. FASEB J. 34(7), 9563\u20139574 (2020)","journal-title":"FASEB J."},{"issue":"8","key":"4527_CR73","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1080\/09513590.2018.1540567","volume":"35","author":"X Li","year":"2019","unstructured":"X. Li, J. Qi, Q. Zhu et al., The role of androgen in autophagy of granulosa cells from PCOS. Gynecol. Endocrinol. 35(8), 669\u2013672 (2019)","journal-title":"Gynecol. Endocrinol."},{"issue":"10","key":"4527_CR74","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1080\/15548627.2021.1938914","volume":"17","author":"V Sanjana Kumariya","year":"2021","unstructured":"V. Sanjana Kumariya, R.K. Ubba, R. Jha, Jiaur, Gayen, Autophagy in ovary and polycystic ovary syndrome: role, dispute and future perspective. Autophagy. 17(10), 2706\u20132733 (2021)","journal-title":"Autophagy"},{"issue":"11","key":"4527_CR75","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1016\/j.celrep.2018.05.032","volume":"23","author":"S Yamamoto","year":"2018","unstructured":"S. Yamamoto, K. Kuramoto, N. Wang et al., Autophagy differetially regulates insulin production and insulin sensitivity. Cell. Rep. 23(11), 3286\u20133299 (2018)","journal-title":"Cell. Rep."},{"issue":"6","key":"4527_CR76","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.cmet.2010.04.005","volume":"11","author":"L Yang","year":"2010","unstructured":"L. Yang, P. Li, S. Fu et al., Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell. Metab. 11(6), 467\u2013478 (2010)","journal-title":"Cell. Metab."},{"key":"4527_CR77","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1080\/09513590.2018.1540567","volume":"35","author":"X Li","year":"2019","unstructured":"X. Li, J. Qi, Q. Zhu et al., The role of androgen in autophagy of granulosa cells from PCOS. Gynecol. Endocrinol. 35, 669\u2013672 (2019)","journal-title":"Gynecol. Endocrinol."},{"key":"4527_CR78","doi-asserted-by":"publisher","first-page":"824","DOI":"10.4161\/auto.9099","volume":"5","author":"YT Wu","year":"2009","unstructured":"Y.T. Wu, H.L. Tan, Q. Huang et al., Activation of the PI3K-Akt-mTOR signaling pathway pro motes necrotic cell death via suppression of autophagy. Autophagy. 5, 824\u2013828 (2009)","journal-title":"Autophagy"},{"key":"4527_CR79","doi-asserted-by":"crossref","unstructured":"X. Li, X. Hu, J. Wang et al., Inhibition of autophagy via activation of PI3K\/Akt\/mTOR pathway contributes to the protection of hesperidin against myocar dial ischemia\/reperfusion injury. Int J Mol Med 42: 1917. 1924. (2018)","DOI":"10.3892\/ijmm.2018.3794"},{"key":"4527_CR80","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12958-020-00677-x","volume":"18","author":"Y Gong","year":"2020","unstructured":"Y. Gong, S. Luo, P. Fan et al., Growth hormone activates PI3K\/Akt signaling and inhibits ROS accumulation and apoptosis in granulosa cells of patients with polycystic ovary syndrome. Reprod. Biol. Endocrinol. 18, 121 (2020)","journal-title":"Reprod. Biol. Endocrinol."},{"key":"4527_CR81","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ebiom.2017.03.023","volume":"18","author":"Y Zhang","year":"2017","unstructured":"Y. Zhang, M. Hu, F. Meng et al., Met Formin ameliorates uterine defects in a rat model of Poly cystic ovary syndrome. EBioMedicine. 18, 157\u2013170 (2017)","journal-title":"EBioMedicine"},{"key":"4527_CR82","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.febslet.2010.01.017","volume":"584","author":"CH Jung","year":"2010","unstructured":"C.H. Jung, S.H. Ro, J. Cao et al., mTOR regulation of autophagy. FEBS Lett. 584, 1287\u20131295 (2010)","journal-title":"FEBS Lett."},{"key":"4527_CR83","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.biopha.2018.04.072","volume":"103","author":"J Yang","year":"2018","unstructured":"J. Yang, C. Pi, G. Wang, Inhibition of PI3K\/Akt\/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells. Biomed. Pharmacother. 103, 699\u2013707 (2018)","journal-title":"Biomed. Pharmacother"},{"issue":"2","key":"4527_CR84","doi-asserted-by":"publisher","first-page":"197","DOI":"10.18632\/aging.101376","volume":"10","author":"YC Sun","year":"2018","unstructured":"Y.C. Sun, Y.Y. Wang, X.F. Sun et al., The role of autophagy during murine primordial follicle assembly. Aging (Albany NY). 10(2), 197\u2013211 (2018)","journal-title":"Aging (Albany NY)"},{"key":"4527_CR85","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1507\/endocrj.EJ21-0480","volume":"69","author":"B Xu","year":"2022","unstructured":"B. Xu, W. Dai, L. Liu et al., Metformin ameliorates polycystic ovary syndrome in a rat model by decreasing excessive autophagy in ovarian granulosa cells via the PI3K\/AKT\/mTOR pathway. Endocr. J. 69, 863\u2013875 (2022)","journal-title":"Endocr. J."},{"issue":"November2019","key":"4527_CR86","doi-asserted-by":"publisher","first-page":"110792","DOI":"10.1016\/j.mce.2020.110792","volume":"508","author":"M Kobayashi","year":"2020","unstructured":"M. Kobayashi, O. Yoshino, A. Nakashima et al., Inhibition of autophagy in Theca cells induces CYP17A1 and PAI-1 expression via ROS\/p38 and JNK signalling during the development of Poly cystic ovary syndrome. Mol. Cell. Endocrinol. 508(November2019), 110792 (2020)","journal-title":"Mol. Cell. Endocrinol."},{"issue":"1\u20132","key":"4527_CR87","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.anireprosci.2005.05.014","volume":"92","author":"T Vanholder","year":"2006","unstructured":"T. Vanholder, J. Lmr Leroy, Van A. Soom et al., Effect of non-esterified fatty acids on bovine Theca cell steroidogenesis and proliferation in vitro. Anim. Reprod. Sci. 92(1\u20132), 51\u201363 (2006)","journal-title":"Anim. Reprod. Sci."},{"issue":"11","key":"4527_CR88","doi-asserted-by":"publisher","first-page":"E2269","DOI":"10.1210\/jc.2013-3942","volume":"99","author":"Z Niu","year":"2014","unstructured":"Z. Niu, N. Lin, R. Gu et al., Associations between insulin resistance, free fatty acids, and oocyte quality in polycystic ovary syndrome during in vitro fertilization. J. Clin. Endocrinol. Metab. 99(11), E2269\u2013E2276 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4527_CR89","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.mce.2016.11.009","volume":"15","author":"M Sumarac-Dumanovic","year":"2017","unstructured":"M. Sumarac-Dumanovic et al., Downregulation of autophagy gene expression in endometria from women with polycystic ovary syndrome. Mol. Cell. Endocrinol. 15, 440:116\u2013124 (2017)","journal-title":"Mol. Cell. Endocrinol."},{"key":"4527_CR90","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1126\/science.1120781","volume":"310","author":"RJ Shaw","year":"2005","unstructured":"R.J. Shaw et al., The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of Metformin. Science. 310, 1642\u20131646 (2005)","journal-title":"Science"},{"key":"4527_CR91","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41586-022-04431-8","volume":"603","author":"T Ma","year":"2022","unstructured":"T. Ma et al., Low-dose Metformin targets the lysosomal AMPK pathway through PEN2. Nature. 603, 159\u2013165 (2022)","journal-title":"Nature"},{"key":"4527_CR92","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nature11808","volume":"494","author":"RA Miller","year":"2013","unstructured":"R.A. Miller et al., Biguanides suppress hepatic glucagon signalling by decreasing production of Cyclic AMP. Nature. 494, 256\u2013260 (2013)","journal-title":"Nature"},{"issue":"10","key":"4527_CR93","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41574-019-0242-2","volume":"15","author":"M Foretz","year":"2019","unstructured":"M. Foretz, B. Guigas, Benoit Viollet, Understanding the glucoregulatory mechanisms of Metformin in type 2 diabetes mellitus. Rev. Nat. Rev. Endocrinol. 15(10), 569\u2013589 (2019). https:\/\/doi.org\/10.1038\/s41574-019-0242-2. Epub 2019 Aug 22","journal-title":"Rev. Nat. Rev. Endocrinol."},{"key":"4527_CR94","doi-asserted-by":"publisher","DOI":"10.1101\/2022.05.22.492936v1","author":"R Kj\u00f8bsted","year":"2022","unstructured":"R. Kj\u00f8bsted et al., Metformin improves glycemia independently of skeletal muscle AMPK via enhanced intestinal glucose clearance. Preprint bioRxiv. (2022). https:\/\/www.biorxiv.org\/content\/https:\/\/doi.org\/10.1101\/2022.05.22.492936v1","journal-title":"Preprint bioRxiv"},{"key":"4527_CR95","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/s41467-022-28743-5","volume":"13","author":"E Zhang","year":"2022","unstructured":"E. Zhang et al., Intestinal AMPK modulation of microbiota mediates crosstalk with brown fat to control thermogenesis. Nat. Commun. 13, 1135 (2022)","journal-title":"Nat. Commun."},{"key":"4527_CR96","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1172\/JCI40671","volume":"120","author":"M Foretz","year":"2010","unstructured":"M. Foretz et al., Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1\/AMPK pathway via a decrease in hepatic energy state. J. Clin. Invest. 120, 2355\u20132369 (2010)","journal-title":"J. Clin. Invest."},{"key":"4527_CR97","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1210\/jcem.77.5.8077342","volume":"77","author":"A. el-Roeiy","year":"1993","unstructured":"A. el-Roeiy, X. Chen, V.J. Roberts et al., Expression of insulin-like growth factor-I (IGF-I) and IGF-II and the IGF-I, IGF-II, and insulin receptor genes and localization of the gene products in the human ovary. J. Clin. Endocrinol. Metab. 77, 1411\u20131418 (1993). https:\/\/doi.org\/10.1210\/jcem.77.5.8077342","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4527_CR98","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/BF00281982","volume":"28","author":"ER Froesch","year":"1985","unstructured":"E.R. Froesch, J. Zapf, Insulin-like growth factors and insulin: comparative aspects. Diabetologia. 28, 485\u2013493 (1985)","journal-title":"Diabetologia"},{"key":"4527_CR99","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1210\/edrv-16-2-143","volume":"16","author":"D. LeRoith","year":"1995","unstructured":"D. LeRoith, H. Werner, D. Beitner-Johnson et al., Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr. Rev. 16, 143\u2013163 (1995). https:\/\/doi.org\/10.1210\/edrv-16-2-143","journal-title":"Endocr. Rev."},{"key":"4527_CR100","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1210\/edrv-12-1-3","volume":"12","author":"L Poretsky","year":"1991","unstructured":"L. Poretsky, On the paradox of insulin-induced hyperandrogenism in insulin-resistant States. Endocr. Rev. 12, 3\u201313 (1991)","journal-title":"Endocr. Rev."},{"key":"4527_CR101","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1210\/jcem.80.12.8530637","volume":"80","author":"D Willis","year":"1995","unstructured":"D. Willis, S. Franks, Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor. J. Clin. Endocrinol. Metab. 80, 3788\u20133737 (1995)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4527_CR102","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1210\/jcem.83.6.4886","volume":"83","author":"J.E. de Nestler","year":"1998","unstructured":"J.E. Nestler, D.J. Jakubowicz, de A.F. Vargas et al., Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J. Clin. Endocrinol. Metab. 83, 2001\u20132005 (1998). https:\/\/doi.org\/10.1210\/jcem.83.6.4886","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3\u20135","key":"4527_CR103","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jsbmb.2008.03.014","volume":"109","author":"E Diamanti-Kandarakis","year":"2008","unstructured":"E. Diamanti-Kandarakis, G. Argyrakopoulou, F. Economou et al., Defects in insulin signaling pathways in ovarian steroidogenesis and other tissues in polycystic ovary syndrome (PCOS). J. Steroid Biochem. Mol. Biol. 109(3\u20135), 242\u2013246 (2008)","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"4527_CR104","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1056\/NEJM199608293350902","volume":"335","author":"JE Nestler","year":"1996","unstructured":"J.E. Nestler, D.J. Jakubowicz, Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N. Engl. J. Med. 335, 617\u2013623 (1996)","journal-title":"N. Engl. J. Med."},{"key":"4527_CR105","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0015-0282(01)01975-6","volume":"76","author":"GR Attia","year":"2001","unstructured":"G.R. Attia, W.E. Rainey, B.R. Carr, Metformin directly inhibits androgen production in human thecal cells. Fertil. Steril. 76, 517\u2013524 (2001)","journal-title":"Fertil. Steril."},{"key":"4527_CR106","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1095\/biolreprod.106.050831","volume":"75","author":"L Tosca","year":"2006","unstructured":"L. Tosca, P. Solnais, P. Ferre et al., Metformininduced stimulation of adenosine 50 monophosphate-activated protein kinase (PRKA) impairs progesterone secretion in rat granulosa cells. Biol. Reprod. 75, 342\u2013351 (2006)","journal-title":"Biol. Reprod."},{"issue":"4","key":"4527_CR107","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/s0015-0282(02)04925-7","volume":"79","author":"R Galea","year":"2003","unstructured":"Rebecca Mansfield 1, R. Galea, M. Brincat et al., Metformin has direct effects on human ovarian steroidogenesis. Fertil. Steril. 79(4), 956\u2013962 (2003). https:\/\/doi.org\/10.1016\/s0015-0282(02)04925-7","journal-title":"Fertil. Steril."},{"key":"4527_CR108","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/S0015-0282(02)04346-7","volume":"78","author":"A La Marca","year":"2002","unstructured":"La A. Marca, G. Morgante, M. Palumbo et al., Insulin-lowering treatment reduces aromatase activity in response to follicle-stimulating hormone in women with polycystic ovary syndrome. Fertil. Steril. 78, 1234\u20131239 (2002)","journal-title":"Fertil. Steril."},{"key":"4527_CR109","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S0015-0282(02)04925-7","volume":"79","author":"R Mansfield","year":"2003","unstructured":"R. Mansfield, R. Galea, M. Brincat et al., Metformin has direct effects on human ovarian steroidogenesis. Fertil. Steril. 79, 956\u2013962 (2003)","journal-title":"Fertil. Steril."},{"key":"4527_CR110","doi-asserted-by":"publisher","first-page":"16767","DOI":"10.1074\/jbc.M100040200","volume":"276","author":"W Arlt","year":"2001","unstructured":"W. Arlt, R.J. Auchus, W.L. Miller, Thiazolidinediones but not Metformin directly inhibit the steroidogenic enzymes P450c17 and 3b-hydroxysteroid dehydrogenase. J. Biol. Chem. 276, 16767\u201316771 (2001)","journal-title":"J. Biol. Chem."},{"issue":"7","key":"4527_CR111","doi-asserted-by":"publisher","first-page":"C491","DOI":"10.1152\/ajpcell.00184.2015","volume":"309","author":"S Gardner","year":"2015","unstructured":"S. Gardner, S.M. Gross, L.L. David et al., Separating myoblast differentiation from muscle cell fusion using IGF-I and the p38 MAP kinase inhibitor SB202190Am. J. Physiol. Cell. Physiol. 309(7), C491\u2013500 (2015). Epub 2015 Aug 5","journal-title":"J. Physiol. Cell. Physiol."},{"issue":"11","key":"4527_CR112","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1002\/jbmr.2282","volume":"29","author":"G Xi","year":"2014","unstructured":"G. Xi, C. Wai, V. DeMambro et al., IGFBP-2 directly stimulates osteoblast differentiation. J. Bone Min. Res. 29(11), 2427\u20132438 (2014)","journal-title":"J. Bone Min. Res."},{"issue":"7","key":"4527_CR113","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1507\/endocrj.EJ21-0480","volume":"69","author":"W Bo Xu","year":"2022","unstructured":"W. Bo Xu\u2006, L. Dai\u2006, Liu et al., Metformin ameliorates polycystic ovary syndrome in a rat model by decreasing excessive autophagy in ovarian granulosa cells via the PI3K\/AKT\/mTOR pathway. Endocr. J. 69(7), 863\u2013875 (2022)","journal-title":"Endocr. J."},{"key":"4527_CR114","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/jcp.22784","volume":"227","author":"A Sayeed","year":"2012","unstructured":"A. Sayeed, N. Alam, A. Trerotola et al., Insulin-like growth factor 1 stimulation of androgen receptor activity requires b1A integrins. J. Cell. Physiol. 227, 751\u2013758 (2012)","journal-title":"J. Cell. Physiol."},{"key":"4527_CR115","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1016\/j.fertnstert.2009.01.096","volume":"93","author":"L Zhang","year":"2010","unstructured":"L. Zhang, Q. Liao, Effects of testosterone and Metformin on glucose metabolism in endometrium. Fertil. Steril. 93, 2295\u20132298 (2010)","journal-title":"Fertil. Steril."},{"issue":"6","key":"4527_CR116","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/BF00615229","volume":"34","author":"M Schulz","year":"1988","unstructured":"M. Schulz, A. Schmoldt, F. Donn et al., The pharmacokinetics of Flutamide and its major metabolites after a single oral dose and during chronic treatment. Eur. J. Clin. Pharmacol. 34(6), 633\u2013636 (1988)","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"4527_CR117","first-page":"19","volume":"47","author":"HY Zhang","year":"2012","unstructured":"H.Y. Zhang, Y.F. Zhang, Y.K. Han et al., Activation and significance of the PI3K\/Akt pathway in endometrium with polycystic ovary syndrome patients. Zhonghua Fu Chan Ke Za Zhi. 47, 19\u201323 (2012)","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"1","key":"4527_CR118","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ando.2009.12.001","volume":"71","author":"A Bachelot","year":"2010","unstructured":"A. Bachelot, N. Chabbert-Buffet, S. Salenave et al., Anti-androgen treatments. Ann. Endocrinol. (Paris). 71(1), 19\u201324 (2010)","journal-title":"Ann. Endocrinol. (Paris)"},{"key":"4527_CR119","doi-asserted-by":"publisher","first-page":"102107","DOI":"10.1016\/j.ygyno.2009.06.033","volume":"115","author":"A Villavicencio","year":"2009","unstructured":"A. Villavicencio, A. Goyeneche, C. Telleria et al., Involvement of Akt, Ras and cell cycle regulators in the potential development of endometrial hyperplasia in women with polycystic ovarian syndrome. Gynecol. Oncol. 115, 102107 (2009)","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"4527_CR120","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0303-7207(86)90132-2","volume":"44","author":"J Simard","year":"1986","unstructured":"J. Simard, I. Luthy, J. Guay et al., Characteristics of interaction of the anti-androgen Flutamide with the androgen receptor in various target tissues. Mol. Cell. Endocrinol. 44(3), 261\u2013270 (1986)","journal-title":"Mol. Cell. Endocrinol."},{"issue":"4","key":"4527_CR121","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1210\/jc.2017-02052","volume":"103","author":"P Barrionuevo","year":"2018","unstructured":"P. Barrionuevo, M. Nabhan, O. Altayar et al., Treatment options for hirsutism: a systematic review and network meta-analysis. J. Clin. Endocrinol. Metab. 103(4), 1258\u20131264 (2018)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"4527_CR122","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/bjd.14486","volume":"175","author":"EJ van Zuuren","year":"2016","unstructured":"van E.J. Zuuren, Z. Fedorowicz, Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review including GRADE assessments. Br. J. Dermatol. 175(1), 45\u201361 (2016)","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"4527_CR123","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12916-020-01516-x","volume":"18","author":"AS Pena","year":"2020","unstructured":"A.S. Pena, S.F. Witchel, K.M. Hoeger, S.E. Oberfield, M.G. Vogiatzi, M. Misso et al., Adolescent polycystic ovary syndrome according to the international evidence-based guideline. BMC Med. 18(1), 72 (2020)","journal-title":"BMC Med."},{"issue":"6","key":"4527_CR124","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1210\/jcem.87.6.8568","volume":"87","author":"L Ibanez","year":"2002","unstructured":"L. Ibanez, C. Valls, A. Ferrer et al., Additive effects of insulin-sensitizing and anti-androgen treatment in young, non-obese women with hyperinsulinism, hyperandrogenism, dyslipidemia, and anovulation. J. Clin. Endocrinol. Metab. 87(6), 2870\u20132874 (2002)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"4527_CR125","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1365-2265.2004.01973.x","volume":"60","author":"A Gambineri","year":"2004","unstructured":"A. Gambineri, C. Pelusi, S. Genghini et al., Effect of Flutamide and Metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome. Clin. Endocrinol. 60(2), 241 (2004)","journal-title":"Clin. Endocrinol."},{"issue":"3","key":"4527_CR126","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1001\/jamadermatol.2016.5790","volume":"153","author":"EJ Van Zuuren","year":"2017","unstructured":"Van E.J. Zuuren, Z. Fedorowicz, Interventions for female pattern hair loss. JAMA Dermatol. 153(3), 329\u2013330 (2017)","journal-title":"JAMA Dermatol."},{"issue":"47","key":"4527_CR127","doi-asserted-by":"publisher","first-page":"83334","DOI":"10.18632\/oncotarget.19833","volume":"8","author":"PA Regidor","year":"2017","unstructured":"P.A. Regidor, A.E. Schindler, Anti-androgenic and antimineralocorticoid health benefits of COC containing newer progestogens: dienogest and Drospirenone. Oncotarget. 8(47), 83334\u201383342 (2017)","journal-title":"Oncotarget"},{"issue":"Suppl 3","key":"4527_CR128","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/13697130500330382","volume":"8","author":"R Sitruk-Ware","year":"2005","unstructured":"R. Sitruk-Ware, Pharmacology of different progestogens: the special case of Drospirenone. Climacteric. 8(Suppl 3), 4\u201312 (2005)","journal-title":"Climacteric"},{"issue":"Suppl 1","key":"4527_CR129","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/13697130500148875","volume":"8","author":"H Kuhl","year":"2005","unstructured":"H. Kuhl, Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric. 8(Suppl 1), 3\u201363 (2005)","journal-title":"Climacteric"},{"issue":"9","key":"4527_CR130","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1080\/09513590.2016.1183629","volume":"32","author":"X Zhao","year":"2016","unstructured":"X. Zhao, X.F. Zhang, Y. Zhao et al., Effect of combined Drospirenone with estradiol for hypertensive postmenopausal women: a systemic review and meta-analysis. Gynecol. Endocrinol. 32(9), 685\u2013689 (2016)","journal-title":"Gynecol. Endocrinol."},{"key":"4527_CR131","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ejogrb.2016.11.013","volume":"210","author":"J Li","year":"2017","unstructured":"J. Li, J. Ren, W. Sun, A comparative systematic review of Yasmin (drospirenone pill) versus standard treatment options for symptoms of polycystic ovary syndrome. Eur. J. Obstet. Gynecol. Reprod. Biol. 210, 13\u201321 (2017)","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"10","key":"4527_CR132","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1530\/EC-20-0423","volume":"9","author":"LS Silva-Bermudez","year":"2020","unstructured":"L.S. Silva-Bermudez, F.J.K. Toloza, M.C. Perez-Matos, de R.J. Souza, L. Banfield, A. Vargas-Villanueva et al., Effects of oral contraceptives on metabolic parameters in adult premenopausal women: a meta-analysis. Endocr. Connect. 9(10), 978\u2013998 (2020)","journal-title":"Endocr. Connect."},{"issue":"9","key":"4527_CR133","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3109\/09513590.2016.1161743","volume":"32","author":"PA Regidor","year":"2016","unstructured":"P.A. Regidor, E. Colli, A.E. Schindler, Drospirenone as estrogen-free pill and hemostasis: coagulatory study results comparing a novel 4\u00a0mg formulation in a 24\u2009+\u20094 cycle with desogestrel 75 \u00b5g per day. Gynecol. Endocrinol. 32(9), 749\u2013751 (2016)","journal-title":"Gynecol. Endocrinol."},{"issue":"1","key":"4527_CR134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12905-020-01080-9","volume":"20","author":"S Palacios","year":"2020","unstructured":"S. Palacios, E. Colli, P.A. Regidor, Efficacy and cardiovascular safety of the new estrogen-free contraceptive pill containing 4\u00a0mg Drospirenone alone in a 24\/4 regime. BMC Womens Health. 20(1), 1\u20139 (2020)","journal-title":"BMC Womens Health"},{"issue":"7","key":"4527_CR135","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1111\/ijd.14370","volume":"58","author":"AC Hu","year":"2019","unstructured":"A.C. Hu, L.W. Chapman, N.A. Mesinkovska, The efficacy and use of finasteride in women: a systematic review. Int. J. Dermatol. 58(7), 759\u2013776 (2019)","journal-title":"Int. J. Dermatol."},{"issue":"1","key":"4527_CR136","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2165\/00003088-199630010-00002","volume":"30","author":"JF Steiner","year":"1996","unstructured":"J.F. Steiner, Clinical pharmacokinetics and pharmacodynamics of finasteride. Clin. Pharmacokinet. 30(1), 16\u201327 (1996)","journal-title":"Clin. Pharmacokinet."},{"issue":"3","key":"4527_CR137","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.fertnstert.2004.02.118","volume":"82","author":"M Tartagni","year":"2004","unstructured":"M. Tartagni, M.M. Schonauer, E. Cicinelli et al., Intermittent lowdose finasteride is as effective as daily administration for the treatment of hirsute women. Fertil. Steril. 82(3), 752\u2013755 (2004)","journal-title":"Fertil. Steril."},{"issue":"1","key":"4527_CR138","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.fertnstert.2009.01.150","volume":"94","author":"M Tartagni","year":"2010","unstructured":"M. Tartagni, E. Cicinelli, De G. Pergola, C. Lavopa, Di E. Naro, De M.A. Salvia et al., Effect of finasteride on ovulation induction in nonresponder (hyperandrogenic) polycystic ovary syndrome (PCOS) women. Fertil. Steril. 94(1), 247\u2013249 (2010)","journal-title":"Fertil. Steril."},{"issue":"6","key":"4527_CR139","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.jaad.2018.08.061","volume":"80","author":"S Azarchi","year":"2019","unstructured":"S. Azarchi, A. Bienenfeld, K. Lo Sicco, S. Marchbein, J. Shapiro, A.R. Nagler, Androgens in women: hormonemodulating therapies for skin disease. J. Am. Acad. Dermatol. 80(6), 1509\u20131521 (2019)","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"4527_CR140","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jpainsymman.2016.12.320","volume":"53","author":"L Carone","year":"2017","unstructured":"L. Carone, S.G. Oxberry, R. Twycross, S. Charlesworth, M. Mihalyo, A. Wilcock, Spironolactone, J. Pain Symptom Manag. 53(2), 288\u2013292 (2017)","journal-title":"J. Pain Symptom Manag"},{"issue":"1\u20132","key":"4527_CR141","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.mce.2003.10.005","volume":"217","author":"SM Garthwaite","year":"2004","unstructured":"S.M. Garthwaite, E.G. McMahon, The evolution of aldosterone antagonists. Mol. Cell. Endocrinol. 217(1\u20132), 27\u201331 (2004)","journal-title":"Mol. Cell. Endocrinol."},{"issue":"8","key":"4527_CR142","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1210\/js.2019-00078","volume":"3","author":"SF Witchel","year":"2019","unstructured":"S.F. Witchel, S.E. Oberfield, A.S. Pena, Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls. J. Endocr. Soc. 3(8), 1545\u20131573 (2019)","journal-title":"J. Endocr. Soc."},{"issue":"11","key":"4527_CR143","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.4158\/EP15748.DSC","volume":"21","author":"NF Goodman","year":"2015","unstructured":"N.F. Goodman, R.H. Cobin, W. Futterweit et al., American association of clinical endocrinologists, American college of endocrinology, and androgen excess and PCOS society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome\u2014 part 1. Endocr. Pract. 21(11), 1291\u20131300 (2015)","journal-title":"Endocr. Pract."},{"issue":"9","key":"4527_CR144","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1210\/jc.2013-1040","volume":"98","author":"MA Ganie","year":"2013","unstructured":"M.A. Ganie, M.L. Khurana, S. Nisar et al., Improved efficacy of low-dose spironolactone and Metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study. J. Clin. Endocrinol. Metab. 98(9), 3599\u20133607 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"4527_CR145","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1210\/jc.2003-031780","volume":"89","author":"M Ashraf Ganie","year":"2004","unstructured":"M. Ashraf Ganie, M.L. Khurana, M. Eunice et al., Comparison of efficacy of spironolactone with Metformin in the management of polycystic ovary syndrome: an open-labeled study. J. Clin. Endocrinol. Metab. 89(6), 2756\u20132762 (2004)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4527_CR146","doi-asserted-by":"publisher","unstructured":"J. Brown, C. Farquhar, O. Lee et al., Spironolactone versus placebo or in combination with steroids for hirsutism and\/or acne. Cochrane Database Syst. Rev. 2009;2, CD000194 https:\/\/doi.org\/10.1002\/14651858.CD000194.pub2","DOI":"10.1002\/14651858.CD000194.pub2"},{"issue":"Suppl 1","key":"4527_CR147","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.maturitas.2003.09.014","volume":"46","author":"AE Schindler","year":"2003","unstructured":"A.E. Schindler, C. Campagnoli, R. Druckmann et al., Classification and Pharmacology of progestins. Maturitas. 46(Suppl 1), S7\u2013S1 (2003)","journal-title":"Maturitas"},{"issue":"3","key":"4527_CR148","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1080\/13625187.2017.1317339","volume":"22","author":"J Bitzer","year":"2017","unstructured":"J. Bitzer, T. Romer, A. Lopes da Silva Filho, The use of cyproterone acetate\/ethinyl estradiol in hyperandrogenic skin symptoms\u2014a review. Eur. J. Contracept. Reprod. Health Care. 22(3), 172\u2013182 (2017)","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"issue":"3","key":"4527_CR149","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/13625187.2017.1317735","volume":"22","author":"X Ruan","year":"2017","unstructured":"X. Ruan, A. Kubba, A. Aguilar et al., Use of cyproterone acetate\/ethinylestradiol in polycystic ovary syndrome: rationale and practical aspects. Eur. J. Contracept. Reprod. Health Care. 22(3), 183\u2013190 (2017)","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"key":"4527_CR150","first-page":"CD001125","volume":"4","author":"ZM van der Spuy","year":"2003","unstructured":"van der Z.M. Spuy, Le P.A. Roux, M.J. Matjila, Cyproterone acetate for hirsutism. Cochrane Database Syst. Rev. 4, CD001125 (2003)","journal-title":"Cochrane Database Syst. Rev."},{"issue":"10","key":"4527_CR151","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.1210\/jc.2005-2250","volume":"91","author":"L Alessandra Gambineri","year":"2006","unstructured":"L. Alessandra Gambineri, A. Patton, Vaccina et al., Treatment with Flutamide, Metformin, and their combination added to a hypocaloric diet in overweight obese women with polycystic ovary syndrome: A Randomized, 12-Month, Placebo-Controlled study. J. Clin. Endocrinol. Metab. 91(10), 3970\u20133980 (2006)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"4527_CR152","first-page":"205","volume":"15","author":"M Mania Amiri","year":"2014","unstructured":"M. Mania Amiri, S. Golsorkhtabaramiri, Esmaeilzadeh et al., Effect of Metformin and Flutamide on anthropometric indices and laboratory tests in Obese\/Overweight PCOS women under hypocaloric diet. J. Reprod. Infertil. 15(4), 205\u2013213 (2014)","journal-title":"J. Reprod. Infertil"},{"issue":"1","key":"4527_CR153","first-page":"84","volume":"13","author":"H Diri","year":"2017","unstructured":"H. Diri, F. Bayram, Y. Simsek et al., Comparison of finasteride, Metformin, and finasteride plus Metformin in PCOS. Acta Endocrinol. 13(1), 84\u201389 (2017)","journal-title":"Acta Endocrinol."},{"issue":"9","key":"4527_CR154","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1345\/aph.1G025","volume":"39","author":"NA Christy","year":"2005","unstructured":"N.A. Christy, A.S. Franks, L.B. Cross, Spironolactone for hirsutism in polycystic ovary syndrome. Ann. Pharmacother. 39(9), 1517\u20131521 (2005)","journal-title":"Ann. Pharmacother"},{"issue":"2","key":"4527_CR155","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.numecd.2013.04.016","volume":"24","author":"A Mazza","year":"2014","unstructured":"A. Mazza, B. Fruci, P. Guzzi et al., In PCOS patients the addition of low-dose spironolactone induces a more marked reduction of clinical and biochemical hyperandrogenism than Met Formin alone. Nutr. Metab. Cardiovasc. Dis. 24(2), 132\u2013139 (2014)","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"1","key":"4527_CR156","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3109\/09513590.2015.1080679","volume":"32","author":"H Diri","year":"2016","unstructured":"H. Diri, S. Karaburgu, B. Acmaz et al., Comparison of spironolactone and spironolactone plus Metformin in the treatment of polycystic ovary syndrome. Gynecol. Endocrinol. 32(1), 42\u201345 (2016)","journal-title":"Gynecol. Endocrinol."},{"key":"4527_CR157","doi-asserted-by":"publisher","unstructured":"L. Tao, Y. Zhang, C. Zeng et al., Effects of Low-Dose spironolactone combined with Metformin or either drug alone on insulin resistance in patients with polycystic ovary syndrome: A pilot study. Int. J. Endocrinol. 2022 Mar. 19:20229927240 https:\/\/doi.org\/10.1155\/2022\/9927240","DOI":"10.1155\/2022\/9927240"},{"key":"4527_CR158","unstructured":"H.T.C.T. Tay, J. Laven et al., on behalf of the International PCOS Network in collaboration with funding, partner and collaborating organisations. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Fertility and Sterility. 2023"},{"key":"4527_CR159","doi-asserted-by":"publisher","unstructured":"P. Eleni Memi, M. Pavli, Papagianni et al., Diagnostic and therapeutic use of oral micronized progesterone in endocrinology. Rev Endocr Metab Disord. 2024 Apr 23. https:\/\/doi.org\/10.1007\/s11154-024-09882-0","DOI":"10.1007\/s11154-024-09882-0"},{"issue":"2","key":"4527_CR160","first-page":"582","volume":"83","author":"CL Pastor","year":"1998","unstructured":"C.L. Pastor, M.L. Griffin-Korf, J.A. Aloi et al., Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to Inhibition by estradiol and progesterone. J. Clin. Endocrinol. Metab. 83(2), 582\u2013590 (1998)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4527_CR161","doi-asserted-by":"publisher","unstructured":"C.A. Eagleson, M.B. Gingrich, C.L. Pastor et al., Polycystic Ovarian Syndrome: Evidence that Flutamide Restores Sensitivity of the gonadotropin-releasing Hormone Pulse Generator To Inhibition by Estradiol and Progesterone. J Clin Endocrinol Metab https:\/\/doi.org\/10.1210\/jcem.85.11.6992}","DOI":"10.1210\/jcem.85.11.6992"},{"key":"4527_CR162","doi-asserted-by":"publisher","first-page":"26457","DOI":"10.1074\/jbc.272.42.26457","volume":"272","author":"K Hara","year":"1997","unstructured":"K. Hara, K. Yonezawa, M.T. Kozlowski et al., 586 and Avruch J. Regulation of eIF-4E BP1 phos phorylation by mTOR. J. Biol. Chem. 272, 26457\u201326463 (1997) https:\/\/doi.org\/10.1074\/jbc.272.42.26457","journal-title":"J. Biol. Chem."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04527-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04527-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04527-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T15:04:48Z","timestamp":1767020688000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04527-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":162,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4527"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04527-x","relation":{},"ISSN":["1559-0100"],"issn-type":[{"type":"electronic","value":"1559-0100"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"5 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"13"}}